SCHEMBL2371139

SCHEMBL2371139

O=S(=O)(NC1CC1)c1ccc(OC(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.56
RECQL P46063 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
DRD2 P14416 1/20 0.53
ADRA1D P25100 1/20 0.53
ADRA1A P35348 1/20 0.53
ADRA1B P35368 1/20 0.53
KMT2A Q03164 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 3/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
GAA P10253 1/20 0.51
POLB P06746 1/20 0.49
PARG Q86W56 1/20 0.48
HTT P42858 2/20 0.47
KIT P10721 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2372012 0.78 KDM4E (0.61) KDM4ERECQLSMN1; SMN2KMT2AALDH1A1
SCHEMBL2447508 0.77 DPP4 (0.62) KDM4ERECQLSMN1; SMN2DRD2ADRA1D
SCHEMBL2373111 0.76 SMN1; SMN2 (0.63) SMN1; SMN2ALDH1A1LMNAGAAHTT
SCHEMBL2373108 0.76 ALOX15 (0.43) SMN1; SMN2KMT2AALDH1A1MEN1LMNA
SCHEMBL2372170 0.75 SMN1; SMN2 (0.68) KDM4ERECQLSMN1; SMN2KMT2ATDP1
SCHEMBL2371138 0.75 FFAR4 (0.43) SMN1; SMN2ALDH1A1LMNAKIT
SCHEMBL5338328 0.73 DRD1 (0.46) SMN1; SMN2KMT2AALDH1A1MEN1LMNA
SCHEMBL5338319 0.73 ALDH3A1 (0.43) SMN1; SMN2KMT2AALDH1A1MEN1LMNA
SCHEMBL20707849 0.73 SMN1; SMN2 (0.47) KDM4ERECQLSMN1; SMN2DRD2ADRA1D
SCHEMBL27960710 0.72 NFKB1 (0.39) SMN1; SMN2DRD2ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US claimed
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP disclosed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US disclosed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS STS, ARSA, TST KDM4E 2481/4885RECQL 1880/4885SMN1; SMN2 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.